COVID-19 was associated with seemingly unperturbed barrier integrity (angiopoietin-2/1 ratio), enhanced glycocalyx degradation (syndecan-1) and elevated levels of angiogenic factors (PDGFs). This evidence concerns the gene ANGPT2 and COVID-19.